Relating smoking, obesity, insulin resistance, and ovarian biomarker changes to the final menstrual period

Annals of the New York Academy of Sciences

Volumn 1204, Issue , 2010, Pages 95-103

  Sowers, Maryfran R ^a,b   McConnell, Daniel ^a   Yosef, Matheos ^a   Jannausch, Mary L ^a   Harlow, Sioban D ^a   Randolph Jr , John F ^b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

anti M llerian hormone; inhibin B; insulin resistance; menopause; obesity; smoking

Indexed keywords

EID: 77956249605     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2010.05523.x     Document Type: Conference Paper

References (46)

1. Sowers, M.F. M. La Pietra. 1995. Menopause: its epidemiology and potential association with chronic diseases. Epidemiol. Rev. 17 : 287 302.
2. Gracia, C.R. et al. 2005. The relationship between obesity and race on inhibin B during the menopause transition. Menopause 12 : 559 566.
3. Vigier, B. et al. 1984. Production of anti-Müllerian hormone: another homology between Sertoli and granulosa cells. Endocrinology 114 : 1315 1320.
4. Durlinger, A.L. et al. 1999. Control of primordial follicle recruitment by anti-Müllerian hormone in the mouse ovary. Endocrinology 140 : 5789 5796.
5. Durlinger, A.L. et al. 2001. Anti-müllerian hormone attenuates the effects of FSH on follicle development in the mouse ovary. Endocrinology 142 : 4891 4899.
6. te Velde, E.R. P.L. Pearson. 2002. The variability of female reproductive aging. Hum. Reprod. Update 8 : 141 154.
7. Sowers, M.F. et al. 2008. Anti-Mullerian hormone (AMH) and inhibin-B in the definition of ovarian aging and the menopause transition. J. Clin. Endocrinol. Metab. 93 : 3478 3483.
8. Welt, C.K. 2004. Regulation and function of inhibins in the normal menstrual cycle. Semin. Reprod. Med. 22 : 187 193.
9. Vale, W., A. Hsueh, C. Rivier J. Yu. 1991. The inhibin/activin family of growth factors. In Peptide Growth Factors and their Receptors, Handbook of Experimental Pharmacology. M.A. Sporn & A.B. Roberts, Eds 211 248. Springer-Verlag. Heidelberg.
10. Pierson, T.M. et al. 2000. Regulable expression of inhibin a in wild-type and inhibin alpha null mice. Molecul. Endocrinol. 14 : 1075 1085.
11. Welt, C., Y. Sidis, H. Kneutmann A. Schneyer. 2002. Activins, inhibins, and follistatins: from endocrinology to signaling. A paradigm for the new millennium. Exp. Biol. Med. (Maywood) 227 : 724 752.
12. Burger, H. et al. 1999. Prospectively measured levels of serum follicle-stimulating hormone, estradiol and the dimeric inhibins during the menopausal transition in a population based cohort of women. J. Clin. Endocrinol. Metab. 84 : 4025 4030.
13. Sowers, M.F. et al. 2008. Follicle stimulating hormone (FSH) and its rate of change to define menopause transition stages. J. Clin. Endocrinol. Metab. 93 : 3958 3964.
14. Burger, H. et al. 1999. Prospectively measured levels of serum follicle-stimulating hormone, estradiol and the dimeric inhibins during the menopausal transition in a population based cohort of women. J. Clin. Endocrinol. Metab. 84 : 4025 4030.
15. Sherman, B.M. S.G. Korenman. 1975. Hormonal characteristics of the human menstrual cycle throughout reproductive life. J. Clin. Invest. 55 : 699 706.
16. Lenton, E.A., L. Sexton, S. Lee I.D. Cooke. 1988. Progressive changes in LH and FSH and LH: FSH ratio in women throughout reproductive life. Maturitas 10 : 35 43.
17. Longcope, C. et al. 1986. Steroid and gonadotropin levels in women during the peri-menopausal years. Maturitas 8 : 189 196.
18. Rannevik, G. et al. 1995. A longitudinal study of the perimenopausal transition: altered profiles of steroid and pituitary hormones, SHBG and bone mineral density. Maturitas 21 : 103 113.
19. Metcalf, M.G. 1986. Incidence of ovulation from the menarche to the menopause: observations of 622 New Zealand women. N.Z. Med. J. 96 : 645 648.
20. Sowers, M.F. et al. 2008. Anti-Mullerian hormone (AMH) and inhibin-B in the definition of ovarian aging and the menopause transition. J. Clin. Endocrinol. Metab. 93 : 3478 3483.
21. Randolph, J.F. Jr. et al. 2003. Reproductive hormones in the early menopausal transition: relationship to ethnicity, body size, and menopausal status. J. Clin. Endocrinol. Metab. 88 : 1516 1522.
22. Haffner, S.M. 1997. Progress in population analyses of insulin resistance syndrome. Ann. N.Y. Acad. Sci. 827 : 1 12.
23. Thiébaut, R. H. Jacqmin-Gadda. 2004. Mixed models for longitudinal left-censored repeated measures. Comput. Methods Prog. Biomed. 74 : 255 260.
24. te Velde, E.R. 1998. Ovarian ageing and postponement of childbearing. Maturitas 30 : 103 104.
25. Sowers, M.F. M. La Pietra. 1995. Menopause: its epidemiology and potential association with chronic diseases. Epidemiol. Rev. 17 : 287 302.
26. Mattison, D.R. S.S. Thorgeirsson. 1978. Smoking and industrial pollution, and their effects on menopause and ovarian cancer. Lancet 1 : 187 188.
27. Paszkowski, T., R.N. Clarke M.D. Hornstein. 2002. Smoking induces oxidative stress inside the Graafian follicle. Hum. Reprod. 17 : 921 925.
28. Valdez, K.E. B.K. Petroff. 2004. Potential roles of the aryl hydrocarbon receptor in female reproductive senescence. Reprod. Biol. 4 : 243 258.
29. Weiss, T. A. Eckert. 1989. Cotinine levels in follicular fluid and serum of IVF patients: effect of granulosa-luteal cell function in bitro. Hum. Reprod. 4 : 482 485.
30. Barbieri, R.L., P.M. McShane K.H. Ryan. 1986. Constituents of cigarette smoke inhibit human granulosa cell aromatase. Fertil. Steril. 46 : 232 236.
31. Zenzes, M.T. et al. 1995. Cadmium accumulation in follicular fluid of women in invitro fertilization-embryo transfer is higher in smokers. Fertil. Steril. 64 : 599 603.
32. Varga, B. et al. 1993. Age-dependent accumulation of cadmium in the human ovary. Reprod. Toxicol. 7 : 225 258.
33. Freeman, E.W. et al. 2005. Follicular phase hormone levels and menstrual bleeding status in the approach to menopause. Fertil. Steril. 83 : 383 392.
34. Pigny, P. et al. 2000. Serum levels of inhibins are differentially altered in patients with polycystic ovary syndrome: effects of being overweight and relevance to hyperandrogenism. Fertil. Steril. 73 : 972 997.
35. Cortet-Rudelli, C. et al. 2002. Obesity and serum luteinizing hormone level have an independent and opposite effect on the serum inhibin B level in patients with polycystic ovary syndrome. Fertil. Steril. 77 : 281 287.
36. Gracia, C.R. et al. 2005. The relationship between obesity and race on inhibin B during the menopause transition. Menopause 12 : 559 566.
37. Gerald Reaven, G., F. Abbasi T. McLaughlin. 2004. Obesity, insulin resistance, and cardiovascular disease. Recent Prog. Horm. Res. 59 : 207 223.
38. Eyvazzadeh, A.D. et al. 2009. The role of the endogenous opioid system in polycystic ovary syndrome. Fertil. Steril. 92 : 1 12.
39. Piltonen, T. et al. 2005. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome. Hum. Reprod. 20 : 1820 1826.
40. Spandorfer, S.D. et al. 2004. Obesity and in vitro fertilization: negative influences on outcome. J. Reprod. Med. 49 : 973 977.
41. Pigny, P. et al. 2003. Elevated serum level of anti-Müllerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest. J. Clin. Endocrinol. Metab. 88 : 5957 5962.
42. Chang, R.J., R.M. Nakamura, H.L. Judd S.A. Kaplan. 1983. Insulin resistance in nonobese patients with polycystic ovarian disease. J. Clin. Endocrinol. Metab. 57 : 356 359.
43. Catteau-Jonard, S. et al. 2008. Anti-Mullerian hormone, its receptor, FSH receptor, and androgen receptor genes are overexpressed by granulosa cells from stimulated follicles in women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 93 : 4456 4461.
44. Jonard, S. D. Dewailly. 2004. The follicular excess in polycystic ovaries, due to intra-ovarian hyperandrogenism, may be the main culprit for the follicular arrest. Hum. Reprod. Update 10 : 107 117.
45. Hughesdon, P.E. 1982. Morphology and morphogenesis of the Stein-Leventhal ovary and of so-called hyperthecosis. Obstet. Gynecol. Surv. 37 : 59 77.
46. Kadowaki, T. 2000. Insights into insulin resistance and type 2 diabetes from knockout mouse models. J. Clin. Invest. 106 : 459 465.